Genelex is a leader in precision medication management. A pioneer in DNA testing since 1987, Genelex now focuses exclusively on pharmacogenetic testing and clinical decision support analytics software that evaluates potential drug-drug and gene-drug interactions. Backed by a powerful combination of innovative analytics software, state-of art laboratory facilities, and expert staff, Genelex has a longstanding commitment to the prevention of dangerous and life-threatening adverse drug events (ADEs).
Each year in the United States, 8.6 million ADEs occur, resulting in more than 100,000 deaths and placing an enormous financial burden on the healthcare system. For nearly 15 years, Genelex has been a trailblazer in the area of genetic testing – focused, innovative, and driven to prevent ADEs.
Since 2000, Genelex has researched and developed unique technologies to provide a real-world solution to the ADE crisis. Genelex’s integrated YouScript® Precision Prescribing System combines DNA Drug Sensitivity Testing with the most comprehensive medication management system available.
- YouScript® identifies at-risk individuals within patient populations, helps medical professionals interpret DNA Drug Sensitivity Testing results, and provides expert support for medication management.
- YouScript® is the first analytics software tool available to prescribers that predicts potential drug-drug and drug-gene interactions based on both cytochrome P450 metabolism and genetic testing.
At Genelex, our goal is to improve quality of life and save healthcare resources by providing the tools essential for precision prescribing, whenever medication decisions are made.